Policy Statements & Letters to Policymakers

For decades, NORD has pursued federal and state policies to improve the lives of Americans impacted by rare diseases. This page is updated daily to provide timely information on our policy efforts. Please contact [email protected] if you have questions or need additional information. 

NORD comments to Utah in opposition to its Section 1115 waiver

Published: Jun 30, 2019
Tagged in: Access to Affordable, Adequate Coverage Medicaid Section 1115 Waivers

Read full statement >

NORD comments to Idaho in opposition of its Section 1332 waiver

Published: Jun 30, 2019
Tagged in: Access to Affordable, Adequate Coverage Section 1332 Waivers

Read full statement >

NORD comments to Delaware in support of its Section 1332 waiver

Published: Jun 29, 2019
Tagged in: Access to Affordable, Adequate Coverage Section 1332 Waivers

Read full statement >

Coalition letter to state insurance commissioners regarding copay accumulator adjustment programs

Published: Jun 26, 2019
Tagged in: Access to Affordable, Adequate Coverage Copay Assistance

Read full statement >

NORD letter to the Senate Committee on Health, Education, Labor and Pensions (HELP) on the Lower Health Care Costs Act of 2019 (S. 1895)

Published: Jun 25, 2019
Tagged in: Access to Affordable Medicines Federal Drug Pricing Legislation in the 116th Congress

Read full statement >

Coalition letter to Congress in support of the Newborn Screening Saves Lives Reauthorization Act (H.R.2507)

Published: Jun 24, 2019
Tagged in: Access to Diagnostics Newborn Screening

Read full statement >

NORD letter to the House Committee on Energy and Commerce in support of the Newborn Screening Saves Lives Reauthorization Act of 2019 (H.R. 2507)

Published: Jun 24, 2019
Tagged in: Access to Diagnostics Newborn Screening

Read full statement >

NORD comments to CMS regarding the new technology add-on payment program

Published: Jun 24, 2019
Tagged in: Access to Affordable, Adequate Coverage Medicare, Medicaid, and Private Health Insurance Coverage

Read full statement >

Coalition comments regarding the Office of Management and Budget’s (OMB) actions to potentially change the index for the calculation of inflation for the federal poverty line

Published: Jun 21, 2019
Tagged in: Access to Affordable, Adequate Coverage Medicare, Medicaid, and Private Health Insurance Coverage

Read full statement >

NORD comments to Montana in support of its Section 1332 waiver to create a reinsurance program

Published: Jun 14, 2019
Tagged in: Access to Affordable, Adequate Coverage Section 1332 Waivers

Read full statement >

NORD comments to Indiana in opposition to its Section 1115 waiver implementing work requirements in Medicaid

Published: Jun 11, 2019
Tagged in: Access to Affordable, Adequate Coverage Medicaid Section 1115 Waivers

Read full statement >

NORD comments to the Institute for Clinical and Economic Review’s (ICER) value assessment framework for 2020

Published: Jun 10, 2019
Tagged in: Access to Affordable Medicines Value-based Pricing Assessments

Read full statement >

Coalition letter to Congress in support of the Vaccine Awareness Campaign to Champion Immunization Nationally and Enhance Safety (VACCINES) Act of 2019 (H.R.2862)

Published: Jun 7, 2019
Tagged in: Access to Affordable, Adequate Coverage Medicare, Medicaid, and Private Health Insurance Coverage

Read full statement >

MAPRx coalition comments regarding draft legislation to cap out-of-pocket costs in Medicare Part D

Published: Jun 6, 2019
Tagged in: Access to Affordable, Adequate Coverage Out of Pocket Prescription Drug Costs

Read full statement >

Coalition letter to Congress in support of the Medical Expense Savings Act (S.110, H.R.2073)

Published: Jun 6, 2019
Tagged in: Access to Affordable, Adequate Coverage Medicare, Medicaid, and Private Health Insurance Coverage

Read full statement >

NORD comments on the Senate Health, Education, Labor, and Pensions (HELP) Committee’s draft legislation, the Lower Health Care Costs Act of 2019

Published: Jun 5, 2019
Tagged in: Access to Affordable Medicines Federal Drug Pricing Legislation in the 116th Congress

Read full statement >

Coalition letter to Congress in opposition to draft legislation that would amend Section 101 of the Patent Act

Published: Jun 3, 2019
Tagged in: Access to Affordable Medicines Federal Drug Pricing Legislation in the 116th Congress

Read full statement >

NORD letter to Texas Governor Greg Abbott in support of SB 747 and SB 748, legislation pertaining to newborn screening

Published: Jun 3, 2019
Tagged in: Access to Diagnostics Newborn Screening

Read full statement >

NORD comments to FDA regarding natural history data registries

Published: May 24, 2019
Tagged in: Access to Innovative Medicines and Therapies Patient Focused Drug Development

Read full statement >

NORD letter to Congress in support of provisions in the new H.R.987, legislation that aims to lower drug costs and improve the Affordable Care Act (ACA)

Published: May 15, 2019
Tagged in: Access to Affordable Medicines Federal Drug Pricing Legislation in the 116th Congress

Read full statement >

Coalition letter to Congress in support of H.R.1010, legislation to prevent the implementation of the 2018 short-term, limited-duration health plan guidance

Published: May 15, 2019
Tagged in: Access to Affordable, Adequate Coverage Short-Term, Limited-Duration Health Plans and Association Health Plans

Read full statement >

Coalition letter to Congress in support of the original H.R.987, legislation to enhance outreach and enrollment activities

Published: May 15, 2019
Tagged in: Access to Affordable Medicines Federal Drug Pricing Legislation in the 116th Congress

Read full statement >

Coalition letter to Congress in support of H.R.1386, legislation to improve the navigator program

Published: May 15, 2019
Tagged in: Access to Affordable, Adequate Coverage Affordable Care Act

Read full statement >

Coalition letter asking Congress to reauthorize the Patient-Centered Outcomes Research Institute

Published: May 13, 2019
Tagged in: Advancing Rare Disease Research and Regulatory Science PCORI

Read full statement >

NORD letter to Illinois in support of HB 2174, legislation to alleviate patient out-of-pocket drug costs

Published: May 13, 2019
Tagged in: Access to Affordable, Adequate Coverage Out of Pocket Prescription Drug Costs

Read full statement >

Coalition letter in support of H.R.986, legislation to reverse harmful Section 1332 guidance

Published: May 8, 2019
Tagged in: Access to Affordable, Adequate Coverage Section 1332 Waivers

Read full statement >

Coalition letter to Congress introducing ourselves and our mission

Published: May 8, 2019
Tagged in: Access to Affordable, Adequate Coverage Affordable Care Act

Read full statement >

Coalition response to a request for information (RFI) on allowing the sale of insurance across state lines

Published: May 6, 2019
Tagged in: Access to Affordable, Adequate Coverage Medicare, Medicaid, and Private Health Insurance Coverage

Read full statement >

Coalition letter to Tennessee Governor Bill Lee in opposition implementing a block grant to fund Medicaid

Published: Apr 29, 2019
Tagged in: Access to Affordable, Adequate Coverage Medicaid Section 1115 Waivers

Read full statement >

Coalition letter to the Administration regarding the potential of a recent memo to hamper FDA

Published: Apr 26, 2019
Tagged in: Access to Innovative Medicines and Therapies Protecting FDA Standards for Safe and Effective Drugs

Read full statement >

Coalition one-pager regarding step therapy reform legislation legislation in Pennsylvania

Published: Apr 24, 2019
Tagged in: Access to Affordable, Adequate Coverage Utilization Management

Read full statement >

Coalition letter to Congress regarding appropriations for the Pediatric Device Consortia (PDC) Grant Program

Published: Apr 18, 2019
Tagged in: Access to Innovative Medicines and Therapies Access to Pediatric Therapies Appropriations

Read full statement >

Coalition letter to Delaware in support of HB 105, step therapy reform legislation

Published: Apr 15, 2019
Tagged in: Access to Affordable, Adequate Coverage Utilization Management

Read full statement >

NORD letter to Wisconsin in support of AB 24/SB 26, step therapy reform legislation

Published: Apr 12, 2019
Tagged in: Access to Affordable, Adequate Coverage Utilization Management

Read full statement >

Coalition statement in support of H.R.1010, legislation that would nullify the recently revised rule on short-term, limited-duration health plans (STLDHP)

Published: Apr 8, 2019
Tagged in: Access to Affordable, Adequate Coverage Medicare, Medicaid, and Private Health Insurance Coverage

Read full statement >

NORD comments to HHS regarding its Proposed Rule on rebates in Medicare Part D and Medicaid managed care

Published: Apr 8, 2019
Tagged in: Access to Affordable, Adequate Coverage Out of Pocket Prescription Drug Costs

Read full statement >

NORD letter to New York in support of A 5762, legislation to create a rare disease advisory council

Published: Apr 4, 2019
Tagged in: Rare Disease Advisory Councils (RDACs)

Read full statement >

Coalition letter to Congress asking for funding for the Emergency Medical Services for Children (EMSC) program

Published: Apr 3, 2019
Tagged in: Access to Affordable, Adequate Coverage Emergency Medical Services

Read full statement >

NORD comments to South Carolina regarding its revised Section 1115 waiver

Published: Apr 2, 2019
Tagged in: Access to Affordable, Adequate Coverage Medicaid Section 1115 Waivers

Read full statement >

Coalition letter to Tennessee in opposition to implementing a block grant to fund Medicaid

Published: Apr 2, 2019
Tagged in: Access to Affordable, Adequate Coverage Medicaid Section 1115 Waivers

Read full statement >

NORD comments to FDA on common issues in rare disease drug development

Published: Apr 2, 2019
Tagged in: Access to Innovative Medicines and Therapies Patient Focused Drug Development

Read full statement >

NORD letter to the House of Representatives in support of the CREATES Act (H.R.965)

Published: Apr 2, 2019
Tagged in: Access to Affordable Medicines Generic Drugs

Read full statement >

Coalition statement lauding federal court decisions to stop the expansion of association health plans and Arkansas’ and Kentucky’s Medicaid work requirements

Published: Mar 29, 2019
Tagged in: Access to Affordable, Adequate Coverage Medicaid Section 1115 Waivers Short-Term, Limited-Duration Health Plans and Association Health Plans

Read full statement >

Coalition statement expressing disappointment at CMS’ approval of Utah’s Section 1115 waiver

Published: Mar 29, 2019
Tagged in: Access to Affordable, Adequate Coverage Medicaid Section 1115 Waivers

Read full statement >

Coalition comments in response to a request for information on grandfathered plans

Published: Mar 27, 2019
Tagged in: Access to Affordable, Adequate Coverage Affordable Care Act

Read full statement >

Coalition statement regarding actions taken by the Administration and the House of Representatives pertaining to the Affordable Care Act (ACA)

Published: Mar 26, 2019
Tagged in: Access to Affordable, Adequate Coverage Affordable Care Act

Read full statement >

NORD comments to FDA regarding submitting guidance on Patient Experience Data (PED)

Published: Mar 21, 2019
Tagged in: Access to Innovative Medicines and Therapies Patient Focused Drug Development

Read full statement >

NORD letter to Washington in support of House Bill 1879, legislation pertaining to utilization management reform

Published: Mar 20, 2019
Tagged in: Access to Affordable, Adequate Coverage Utilization Management

Read full statement >

NORD letter to Illinois in support of House Bill 2174, legislation seeking to lower out-of-pocket drug costs

Published: Mar 19, 2019
Tagged in: Access to Affordable, Adequate Coverage Out of Pocket Prescription Drug Costs

Read full statement >

NORD letter to West Virginia Governor Jim Justice in support of House Bill 2770

Published: Mar 15, 2019
Tagged in: Access to Affordable, Adequate Coverage Out of Pocket Prescription Drug Costs

Read full statement >